Bold zebrafish (Danio rerio) express higher levels of delta opioid and dopamine D2 receptors in the brain compared to shy fish.
Animal personality
Behavior
Boldness
Dopamine receptor
Opioid receptor
Risk taking
Shyness
Journal
Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
22
12
2017
revised:
28
05
2018
accepted:
19
06
2018
pubmed:
24
6
2018
medline:
4
4
2019
entrez:
24
6
2018
Statut:
ppublish
Résumé
Individual variation in coping with environmental challenges is a well-known phenomenon across vertebrates, including teleost fish. Dopamine is the major transmitter in the brain reward networks, and important for motivational processes and stress coping. Functions of the endogenous opioid system are not well studied in teleosts. However, in mammals the activity in the brain reward networks is regulated by the endogenous opioid system. This study aimed at investigating if there was a correlation between risk-taking behavior and the expression of dopamine and opioid receptors in the zebrafish (Danio rerio) brain. Risk-taking behavior was assessed in a novel tank diving test, and the most extreme high risk taking, i.e. bold, and low risk taking, i.e. shy, fish were sampled for qPCR analysis of whole brain gene expression. The expression analysis showed a significantly higher expression of the dopamine D2 receptors (drd2a and drd2b) and the delta opioid receptor (DOR; oprd1b) in bold compared to shy fish. Besides reward and reinforcing properties, DORs are also involved in emotional responses. Dopamine D2 receptors are believed to be important for active stress coping in rodents, and taken together the results of the current study suggest similar functions in zebrafish. However, additional experiments are required to clarify how dopamine and opioid receptor activation affect behavior and stress coping in this species.
Identifiants
pubmed: 29935279
pii: S0166-4328(17)32048-X
doi: 10.1016/j.bbr.2018.06.017
pii:
doi:
Substances chimiques
Receptors, Dopamine D2
0
Receptors, Opioid, delta
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
927-934Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.